European Archives - Page 93 of 994 - European Medical Journal

Interview: Sara Tolaney

Sara Tolaney – I started having an interest in medicine from a young age. Part of what drove my interest was having various family members…

Real-World Evidence of Hypertrophic Cardiomyopathy and Mavacamten

George Cooper is joined by Perry Elliott, Professor of Cardiovascular Medicine at University College London, UK, and Anjali Owens…

4 Oct 2024

The Unspeakable Disease: A Tale of Two Siblings

The deficiency of arylsulfatase A due to the mutations in the ARSA gene is the cause of a rare inherited lysosomal storage disease…

Ultrasound Achieves 96% Sensitivity in Detecting Postmenopausal Ovarian Cancer

Ovarian cancer is a global challenge, with most cases diagnosed late. The IOTA ADNEX model offers high sensitivity for earlier detection, but managing false positives is crucial.

world in hands

Gilead expands access to PrEP HIV candidate in 120 countries

A new licensing agreement from Gilead Sciences and six generic drug manufacturers is poised to transform HIV prevention efforts

Interview: Philippe Froguel

Today, the priority populations to target to prevent diabetes should be young adults who have inadequate diets. This information should guide public health action to prevent diabetes.

Urological Cancer Care: A Patient-Centred Approach

Jonathan is joined by medical innovator Kyle Richards, to discuss the most exciting advancements in the field of prostate and bladder cancer therapeutics.

Rise in Oropharynx Cancer Rates in Scotland Over the Past 20 Years

A new study has highlighted shifting trends in head and neck cancers in Scotland, particularly focusing on the past two decades

Preconception Prediabetes Increases Risk of Adverse Birth Outcomes

A study shows that adolescents with prediabetes have a higher risk of developing gestational diabetes and adverse birth outcomes, highlighting the need for early intervention.

AZ's Dr Sunil Verma on the next chapter in cancer care

Ever wondered what one of the world’s top oncology leaders believes to be the next big thing in cancer care? Find out in our interview AstraZeneca’s Dr Sunil Verma.